PT  - JOURNAL ARTICLE
AU  - Safdar, Nasia
AU  - Moreno, Gage K.
AU  - Braun, Katarina M.
AU  - Friedrich, Thomas C.
AU  - O’Connor, David H.
TI  - Determining the source of transmission of SARS-CoV-2 infection in a healthcare worker
AID  - 10.1101/2020.04.27.20077016
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.27.20077016
4099  - http://medrxiv.org/content/early/2020/05/01/2020.04.27.20077016.short
4100  - http://medrxiv.org/content/early/2020/05/01/2020.04.27.20077016.full
AB  - Background Healthcare workers (HCWs) are at the frontlines of the COVID-19 pandemic and are at risk of exposure to SARS-CoV-2 infection from their interactions with patients and in the community (1, 2). Limited availability of recommended personal protective equipment (PPE), in particular N95 respirators, has fueled concerns about whether HCWs are adequately protected from exposure while caring for patients. Understanding the source of SARS-CoV-2 infection in a HCW – the community or the healthcare system – is critical for understanding the effectiveness of hospital infection control and PPE practices. In Dane County, Wisconsin, community prevalence of SARS-CoV-2 is relatively low (cumulative prevalence of ~0.06% – positive cases / total population in Dane county as of April 17). Although SARS-CoV-2 infections in HCWs are often presumed to be acquired during the course of patient care, there are few reports unambiguously identifying the source of acquisition.Objective To determine the source of transmission of SARS-CoV-2 in a healthcare worker.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: NS is supported by NIH Award: 1DP2AI144244-01. GKM is supported by NSF Award: HRD-1612530. KMB was supported by NIH F30 Award: AI145182-01A1.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data files are available on GISAID (EPI_ISL_425167, EPI_ISL_425175, EPI_ISL_425176, EPI_ISL_427427) and SRA in BioProject PRJNA614504 (SRX8114920, SRX8114929, SRX8114930). All bioinformatic pipelines used to analyze the data are available on GitHub in the following public repository: https://github.com/katarinabraun/SARS-CoV-2_sequencing/tree/master/Pipelines_to_process_data/Nanopore_pipeline_ARTIC. https://github.com/katarinabraun/SARS-CoV-2_sequencing/tree/master/Pipelines_to_process_data/Nanopore_pipeline_ARTIC